Nai‐Jung Chiang

1.5k total citations
87 papers, 874 citations indexed

About

Nai‐Jung Chiang is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nai‐Jung Chiang has authored 87 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 44 papers in Surgery and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nai‐Jung Chiang's work include Pancreatic and Hepatic Oncology Research (32 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers) and Cancer Genomics and Diagnostics (11 papers). Nai‐Jung Chiang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (32 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers) and Cancer Genomics and Diagnostics (11 papers). Nai‐Jung Chiang collaborates with scholars based in Taiwan, United States and Poland. Nai‐Jung Chiang's co-authors include Li‐Tzong Chen, Yan‐Shen Shan, Yung‐Yeh Su, Gwo‐Bin Lee, Jang‐Yang Chang, Jeffrey S. Chang, Chien‐Feng Li, Chih‐Hsun Lin, Hsu Ma and Priya Gopinathan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Nai‐Jung Chiang

79 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nai‐Jung Chiang Taiwan 18 367 313 268 234 117 87 874
Xiuyun Tian China 18 400 1.1× 213 0.7× 403 1.5× 264 1.1× 178 1.5× 78 1.1k
Tatsuya Manabe Japan 18 544 1.5× 318 1.0× 245 0.9× 157 0.7× 153 1.3× 63 1.0k
Yoshimasa Akashi Japan 14 262 0.7× 164 0.5× 177 0.7× 184 0.8× 61 0.5× 62 610
Dong Yi Kim South Korea 15 259 0.7× 328 1.0× 159 0.6× 435 1.9× 113 1.0× 43 896
Ping Lan China 18 655 1.8× 446 1.4× 160 0.6× 248 1.1× 71 0.6× 83 1.1k
Diego M. Avella United States 19 462 1.3× 213 0.7× 299 1.1× 215 0.9× 167 1.4× 38 1.0k
Yasuhisa Koyanagi Japan 18 470 1.3× 395 1.3× 313 1.2× 247 1.1× 129 1.1× 97 1.2k
Quan P. Ly United States 19 405 1.1× 177 0.6× 331 1.2× 141 0.6× 188 1.6× 42 922
Luo‐Wei Wang China 15 318 0.9× 403 1.3× 223 0.8× 416 1.8× 97 0.8× 58 944
Dirk Bausch Germany 21 928 2.5× 630 2.0× 341 1.3× 384 1.6× 201 1.7× 69 1.4k

Countries citing papers authored by Nai‐Jung Chiang

Since Specialization
Citations

This map shows the geographic impact of Nai‐Jung Chiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nai‐Jung Chiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nai‐Jung Chiang more than expected).

Fields of papers citing papers by Nai‐Jung Chiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nai‐Jung Chiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nai‐Jung Chiang. The network helps show where Nai‐Jung Chiang may publish in the future.

Co-authorship network of co-authors of Nai‐Jung Chiang

This figure shows the co-authorship network connecting the top 25 collaborators of Nai‐Jung Chiang. A scholar is included among the top collaborators of Nai‐Jung Chiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nai‐Jung Chiang. Nai‐Jung Chiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lin, Yi‐Ting, et al.. (2025). The correlation between LAG-3 expression and the efficacy of chemoimmunotherapy in advanced biliary tract cancer. Cancer Immunology Immunotherapy. 74(2). 41–41. 2 indexed citations
3.
Huang, Chien-Jung, Guan‐Ting Liu, Yu‐Chan Chang, et al.. (2025). Construction of hot tumor classification models in gastrointestinal cancers. Journal of Translational Medicine. 23(1). 218–218. 1 indexed citations
4.
Chiang, Nai‐Jung, et al.. (2025). Application of CAPTURE Assay for Early Diagnosis and Prognosis in Bile and Blood of Cholangiocarcinoma. JCO Precision Oncology. 9(9). e2400728–e2400728. 1 indexed citations
5.
Chen, San‐Chi, et al.. (2025). PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma. BMC Cancer. 25(1). 199–199. 3 indexed citations
6.
Chiang, Nai‐Jung, Chung‐Ping Hsu, Jin‐Shing Chen, et al.. (2024). MO50-3 TCOG T3221 study: the registry of genetic alterations of Taiwan biliary tract cancer. Annals of Oncology. 35. S1355–S1355. 1 indexed citations
7.
8.
Su, Yung‐Yeh, Nai‐Jung Chiang, Yi‐Hsin Yang, et al.. (2023). Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer. Cancers. 15(4). 1008–1008. 5 indexed citations
9.
Chiang, Nai‐Jung, et al.. (2023). An integrated microfluidic system for automatic detection of cholangiocarcinoma cells from bile. Lab on a Chip. 24(2). 375–382. 4 indexed citations
10.
Su, Yung‐Yeh, Nai‐Jung Chiang, Tai‐Jan Chiu, et al.. (2023). Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation. Biomedical Journal. 47(3). 100696–100696. 1 indexed citations
11.
Su, Yung‐Yeh, Ying‐Jui Chao, Chih‐Jung Wang, et al.. (2023). The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study. International Journal of Surgery. 109(9). 2614–2623. 6 indexed citations
12.
Chang, Yu‐Chan, Ya-Chi Hung, Yi‐Ping Hung, et al.. (2022). A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer. Neoplasia. 35. 100856–100856. 11 indexed citations
13.
Chiang, Nai‐Jung, et al.. (2022). Transferrin and Prealbumin Identify Esophageal Cancer Patients with Malnutrition and Poor Prognosis in Patients with Normal Albuminemia: A Cohort Study. Nutrition and Cancer. 74(10). 3546–3555. 12 indexed citations
14.
Chen, Ying‐Yuan, et al.. (2021). Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma. PLoS ONE. 16(5). e0251811–e0251811. 20 indexed citations
15.
Chiang, Nai‐Jung, Li‐Tzong Chen, Yan‐Shen Shan, Chun‐Nan Yeh, & Ming‐Huang Chen. (2021). Development of Possible Next Line of Systemic Therapies for Gemcitabine-Resistant Biliary Tract Cancers: A Perspective from Clinical Trials. Biomolecules. 11(1). 97–97. 5 indexed citations
16.
Gopinathan, Priya, et al.. (2021). Exfoliated tumor cells in bile as a promising indicator of disease status in cholangiocarcinoma. Sensors and Actuators B Chemical. 346. 130526–130526. 3 indexed citations
17.
Su, Yung‐Yeh, Nai‐Jung Chiang, Hui‐Jen Tsai, et al.. (2020). The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort. Scientific Reports. 10(1). 7420–7420. 22 indexed citations
18.
Lin, Forn-Chia, Wei-Lun Chang, Nai‐Jung Chiang, et al.. (2020). Radiation dose escalation can improve local disease control and survival among esophageal cancer patients with large primary tumor volume receiving definitive chemoradiotherapy. PLoS ONE. 15(8). e0237114–e0237114. 9 indexed citations
19.
Chiang, Nai‐Jung, Jang‐Yang Chang, Yan‐Shen Shan, & Li‐Tzong Chen. (2016). Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancer. Expert Opinion on Pharmacotherapy. 17(10). 1413–1420. 17 indexed citations
20.
Chiang, Nai‐Jung, et al.. (2011). Anaplastic Lymphoma Kinase (ALK) Inhibitors: New Cancer Breakthroughs for Lung Cancer. 27(4). 143–156. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiuyun Tian Breakdown of academic impact, for papers by Tatsuya Manabe Breakdown of academic impact, for papers by Yoshimasa Akashi Breakdown of academic impact, for papers by Dong Yi Kim Breakdown of academic impact, for papers by Ping Lan Breakdown of academic impact, for papers by Diego M. Avella Breakdown of academic impact, for papers by Yasuhisa Koyanagi Breakdown of academic impact, for papers by Quan P. Ly Breakdown of academic impact, for papers by Luo‐Wei Wang Breakdown of academic impact, for papers by Dirk Bausch
Rankless by CCL
2026